Tuesday, February 14, 2017

NPR Notícias de negócios: Duchenne Drug Delayed After Outrage Over Price

Duchenne Drug Delayed After Outrage Over Price
Many Duchenne muscular dystrophy patients in the U.S. have imported a medicine called deflazacort for about $1,200 a year. A brand-name version just approved for sale in America costs $89,000.

leia mais em NPR

No comments:

Post a Comment